1. The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study;Murphy;Front. Med. (Lausanne),2022
2. ICH, ICH Topic Q 8 (R2) Pharmaceutical Development Step 5 NOTE FOR GUIDANCE ON PHARMACEUTICAL DEVELOPMENT, 2009. http://www.emea.europa.eu.
3. European Commission, REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL, 2006. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32006R1901&from=EN (accessed February 26, 2023).
4. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) Paediatric Committee (PDCO) Guideline on pharmaceutical development of medicines for paediatric use Guideline on pharmaceutical development of medicines for paediatric use, 2013. www.ema.europa.eu.
5. Children’s views on taking medicines and participating in clinical trials;Nordenmalm;Arch Dis Child,2019